Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
D.R. Horton
DHI
Lennar Corp
LEN
Vale SA
VALE
US Stock MarketDetailed Quotes
RVNC Revance Therapeutics
- 3.065
- -0.015-0.49%
Trading Dec 27 11:52 ET
319.95MMarket Cap-1.60P/E (TTM)
3.080High3.060Low629.25KVolume3.080Open3.080Pre Close1.93MTurnover0.66%Turnover RatioLossP/E (Static)104.39MShares9.74552wk High-1.96P/B294.03MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM0.65%Amplitude2.300Historical Low3.069Avg Price1Lot Size
Revance Therapeutics News
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 424B5: Prospectus
Revance Therapeutics | 424B5: Prospectus
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.